Deploying NMR for the Product Characterization of Protein Therapeutics in Regulatory Submissions
Webinar Overview
Nuclear Magnetic Resonance (NMR) spectroscopy is a vital tool for analyzing protein structure and function. Unlike traditional biophysical methods, NMR enables the study of proteins in their natural and dynamic states with greater sensitivity and detailed information. This presentation will highlight current NMR techniques and compare them to conventional methods for characterizing protein therapeutics. Using NMR in regulatory processes strengthens drug characterization and supports adherence to regulatory standards. As biopharmaceuticals advance, NMR's role in drug development and approval will become increasingly important.
Tuesday, 18 November 2025
5 PM CET / 11 AM EST
Key Learning Points
- Protein Therapeutics Characterization: Learn about how NMR methods used in comprehensive protein analysis are applied from early development through to market approval.
- Characterization of Protein Therapeutics in Regulatory Submissions: Explore how NMR deliver critical structural and functional data that can support regulatory filings, ensuring product quality and consistency.
- NMR in Regulatory Processes: Integrate the unique advantages of NMR to address challenging regulatory expectations and supporting successful filling of biopharmaceuticals.
What to Expect
Gain practical insights into how Nuclear Magnetic Resonance (NMR) is advancing the characterization of protein therapeutics for regulatory submissions. This webinar will address how NMR based method can be used to support the detection and comparison of high order structure of protein therapeutics and report potential deviations.
Who should attend?
This webinar is ideal for scientists and biopharma leaders working on protein therapeutics characterization, experts in biotherapeutics development and bioprocessing specialists. Anyone involved in advanced characterization techniques, including those involved in bioprocess development and/or those supporting regulatory filling will benefit from the session.